New study aims to help older breast cancer patients cope with treatment side effects
NCT ID NCT07232056
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two support programs for women aged 65 and older with hormone-sensitive breast cancer who are taking aromatase inhibitors. The programs include a clinic-level geriatric assessment and support, and a telehealth coping skills training based on cognitive behavioral therapy. The goal is to reduce pain and improve quality of life. The trial plans to enroll 452 participants across multiple sites.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Geriatric oncology assessment and support program (GOAL-AI) and CBT-based coping skills training (CST-AI)
What this could lead to
If successful, these programs could provide a practical way to reduce pain and improve daily life for older women on hormone therapy.
What could go wrong
This is a behavioral intervention trial, so results depend on participant engagement and may not apply to all patients. The study has not yet started recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER, HORMONE RECEPTOR POSITIVE, AROMATASE INHIBITOR-ASSOCIATED ARTHRALGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••